Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Natarajan Ravendhran is a hepatologist specializing in the diagnosis, treatment and management of liver diseases. He received his medical degree from Stanley Medical College, University of Madras in India, completed his residency in internal medicine at what is now Ascension Saint Agnes Hospital in Maryland and a residency in surgery at Railway Hospital in Madras, India. Dr. Ravendhran performed fellowship training in hepatology under the mentorship of Eugene and Leon Schiff at the University of Miami. Additionally, he received fellowship training in gastroenterology and liver disease at the University of Missouri. Dr. Ravendhran received a master’s degree in business administration in medical services management from The Johns Hopkins University. He is a fellow of the American Association for the Study of Liver Diseases and the American Gastroenterological Association, and is a member of the European Association for the Study of the Liver. Dr. Ravendhran is interested in exploring cholestatic disorders. He has participated in many clinical trials that focus on hepatitis B and C, in addition to metabolic dysfunction-associated steatotic liver disease trials. He enjoys teaching, rounding with fellows and seeing patients, and his motto is “Patients come first!”. Dr. Ravendhran is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis, Visceromegaly, Enlarged Liver, and Endoscopy.

Dr. Chloe Thio is a professor of medicine and an associate professor of molecular microbiology and immunology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include hepatitis, HIV/AIDS and infectious disease. Dr. Thio received her B.A. from the University of Pennsylvania. She earned her M.D. from the Yale University School of Medicine. She completed her residency at Hospital of the University of Pennsylvania and her fellowship in infectious diseases at Johns Hopkins. Her research interests include chronic hepatitis B and C and coinfection of viral hepatitis with HIV/AIDS. She has developed a program centered around virology and immunology translational work towards an HBV cure. Dr. Thio is a member of the American College of Physicians, the American Association for the Study of Liver Disease, the American Society of Clinical Investigation, HIVMA and the Infectious Diseases Society of America. Dr. Thio is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, and HIV/AIDS.

Dr. Christopher Hoffmann's primary appointment is in the Department of Medicine, Division of Infectious Diseases. His areas of clinical expertise include HIV/AIDS and infectious diseases. Dr. Hoffmann earned his M.D. and M.P.H. from Oregon Health and Sciences University. He completed his residency at Johns Hopkins and performed a fellowship in infectious diseases at Johns Hopkins. His research interests include care delivery and care utilization, in low- and middle-income settings (mostly Africa), and clinical management of HIV and TB. Dr. Hoffmann is a member of several professional organizations, including the American College of Physicians and the Infectious Diseases Society of America. Dr. Hoffmann is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Kathleen Schwarz is a Hepatologist in Baltimore, Maryland. Dr. Schwarz is rated as a Distinguished provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Sclerosing Cholangitis, and Liver Transplant.

Paul Thuluvath is a Gastroenterologist in Lutherville, Maryland. Dr. Thuluvath is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Liver Failure, Hepatitis, Hepatitis C, Liver Transplant, and Endoscopy.

Jin Gu is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Gu is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, Bone Marrow Aspiration, and Endoscopy.

David Riedel is an Infectious Disease provider in Towson, Maryland. Dr. Riedel is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Febrile Neutropenia, Myelitis, and AIDS Dementia Complex. Dr. Riedel is currently accepting new patients.

Holly Dahlman is a primary care provider, practicing in Internal Medicine in Lutherville, Maryland. Dr. Dahlman is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Osteomyelitis in Children. Dr. Dahlman is currently accepting new patients.

Anusha Vittal is a Gastroenterologist in Baltimore, Maryland. Dr. Vittal is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Banti's Syndrome, Portal Hypertension, Enlarged Liver, Colonoscopy, and Endoscopy.

Chandralekha Banerjee is an Infectious Disease provider in Baltimore, Maryland. Dr. Banerjee is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, and AIDS Dementia Complex. Dr. Banerjee is currently accepting new patients.

Joseph Lin is a Gastroenterologist in Rosedale, Maryland. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Attenuated Familial Adenomatous Polyposis, Juvenile Polyposis Syndrome, Cronkhite-Canada Disease, and Lactose Intolerance.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Ashwin Balagopal is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is infectious diseases. After receiving his medical degree from Mount Sinai School of Medicine, Dr. Balagopal completed his residency in internal medicine at Yale-New Haven Hospital. He performed his fellowship in infectious diseases at the Johns Hopkins University School of Medicine. Dr. Balagopal's research interests include microbial translocation and Kupffer cells in HIV-HCV coinfection and in situ liver studies of HIV-HCV pathogenesis. Dr. Balagopal is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Hepatitis C, HIV/AIDS, and Hepatitis B.

Dr. Gurakar joined Johns Hopkins from the Nazih Zuhdi Transplantation Institute at the Integris Baptist Medical Center in Oklahoma City, where he was the chief of Hepatology Research and the program director of the Liver Transplantation Medicine/ Hepatology Fellowship. He served at various capacities in the Liver Medicine Section, since its first establishment in 1993. Dr. Gurakar's clinical interests include pre and post-transplant, clinical and endoscopic management of liver diseases and viral hepatitis. His research interests include bioartificial liver dialysis systems and application of total plasma exchange in the treatment of liver disorders. Dr. Gurakar is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis, Liver Failure, Alcoholic Cirrhosis, Liver Transplant, and Kidney Transplant.

Dr. Onwueme graduated with Distinction from Yale University with dual BSc/MSc degrees in chemistry and received MD and PhD degrees from Weill Cornell Medical College. He completed his Internal Medicine residency at Brigham and Women’s Hospital (Clinical Fellow Harvard Medical School) and his Gastroenterology fellowship at Johns Hopkins University School of Medicine. He is currently the Director of clinical trials at Woodholme Gastroenterology and has an ardent interest in the role of microbial metabolites in gut diseases. Dr. Onwueme prizes commitment to quality and compassionate patient care to which he devotes his practice. He has expert knowledge in gut microbiology and a special interest in diarrheal diseases, disordered gut motility, autoimmune and inflammatory bowel disease. Dr. Onwueme is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Gastric Dysmotility, Diverticular Disease, Diarrhea, Endoscopy, and Gastrectomy.

Loc Le is a Gastroenterologist in Baltimore, Maryland. Dr. Le is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Barrett Esophagus, Colonoscopy, and Endoscopy.

Shyamasundaran Kottilil is an Infectious Disease provider in Baltimore, Maryland. Dr. Kottilil is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B. Dr. Kottilil is currently accepting new patients.

Saleh Alqahtani is a Gastroenterologist in Baltimore, Maryland. Dr. Alqahtani is rated as an Advanced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Obesity, Hepatitis, Liver Transplant, and Hepato-Pancreato-Biliary Surgery. Dr. Alqahtani is currently accepting new patients.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Experienced provider by MediFind in the treatment of Hepatitis B. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.